<DOC>
	<DOCNO>NCT02698696</DOCNO>
	<brief_summary>This study evaluate effect new cognitive remediation program design patient suffer bipolar disorder , cognitive function , psychosocial function neural process . In double-blind ( patient , outcomes assessor ) control randomized trial investigator compare patient receive ECo program bipolar disorder , patient benefit broadly use cognitive remediation program CRT patient receive supportive psychotherapy . Patients treat 3 month monitor 9 month .</brief_summary>
	<brief_title>Validation Cognitive Remediation Program Bipolar Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>1 . Type I type II Bipolar Disorder diagnosis , accord DSMIVTR criterion 2 . No Manic Major Depressive episode last three month 3 . No residual depressive symptom ( HDRS17 ≤ 12 ) 4 . No residual manic symptom ( YMRS ≤ 8 ) 5 . Stable dose medication last two month 6 . Cognitive complaint express patient impairment observe patient 's regular psychiatrist 7 . Informed consent form read , initial sign 8 . Patient register social welfare system 1 . Other diagnosis Bipolar Disorder axis I DSMIVTR 2 . Rapid Cycling Bipolar Disorder diagnosis 3 . Addiction substance abuse ( except tobacco ) twelve last month 4 . Physical neurological disorder lead cognitive impairment 5 . Engagement research protocol either currently last month 6 . Neuropsychological assessment Rorschach Inkblot Test evaluation last six month 7 . Ineligibility Magnetic Resonance Imaging [ MRI ] ( e.g . claustrophobia , metallic implant , pacemaker , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Cognitive Remediation</keyword>
	<keyword>Mood disorder</keyword>
	<keyword>Neuropsychology</keyword>
</DOC>